| Sandoz Pharmaceuticals AG - Axitinib Sandoz 5 mg, Filmtabletten | | 69472 | | 03 | | Axitinib Sandoz 5 mg | | Filmtabletten | | L01EK01 | | Axitinib | | 22.02.2024 | | |
| | Composition | | axitinibum 5 mg, lactosum monohydricum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.46 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, E 171, E 172 (rubrum), triacetinum, pro compresso obducto corresp. lactosum monohydricum 165.60 mg. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Axitinibum | 5 mg |
| | | | Inactive agents | | additional_information |
|---|
| (Rubrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Triacetinum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | 28 | PR | PR | A | | No | | 005 | 56 | PR | PR | A | | No |
|
|
